Association between interleukln-8 in lung tissues and stages of chronic obstructive pulmonary diseases

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 5, 2009, Pages 885-888

  Hu, Xiao Rong ^a   Han, Su Xia ^a   Wang, Tao ^a   Zhang, Ming Ke ^a   Chen, Lei ^a   Wen, Fu Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary diseases; Cigarette smoking; Interleukin 8; Lung function

Indexed keywords

BIOLOGICAL MARKER; IL8 PROTEIN, HUMAN; INTERLEUKIN 8; MESSENGER RNA;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION; FEMALE; GENETICS; HUMAN; LUNG; MALE; METABOLISM; MIDDLE AGED; SMOKING;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-8; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, MESSENGER; SMOKING;

EID: 70349750368     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med,2007;176(6) ,532-555.
2. Yamamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin 8. Chest,1997,112(2)s505-510. (Pubitemid 27349446)
3. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharrnacol Rev,2004,56(4) ,515-548.
4. Mukaida N. Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol, 2003,284(4) ,566-577.
5. Culpitt SV, Rogers DF, Shah P, et al. Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2003,167(1),24-31.
6. Schulz C, Wolf K, Harth M, et al. Expression and release of interleukin-8 by human bronchial epithelial cells from patients with chronic obstructive pulmonary disease, smokers, and never-smokers. Respiration, 2003,70(3) ,254-261.
7. Nocker RE, Schoonbrood DF, van de Graaf EA, et al. Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol,1996,109(2) ,183-191.
8. Yarnamoto C, Yoneda T, Yoshikawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin 8. Chest,1997,112(2),505-510. (Pubitemid 27349446)
9. Orosz Z, Csiszar A, Labinskyy N, et al. Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD( P) H oxidase activation. Am J Physiol Heart Circ Physiol,2007,292(1) ,H130-139.
10. Szulakowski P, Crowther AJL, Jimenez LA, et al. The effect of smoking on the transcriptional regulation of lung inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2006,174(1) ,41-50.
11. Schulz C, Kratzel K, Wolf K, et al. Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD. Chest,2004,125(5) ,1706-1713.
12. Profita M, Chiappara G, Mirabella F, et al. Effect of cilomilsst (Ariflo) on TNF-a, IL-8 and GM-CSF release by airway cells of patients with COPD. Thorax, 2003,58(7) :573-579.